Trait centric view

1. Trait name:	Body weight
   Ontology terms:	VT:0001259, CMO:0000012

   62 genes are associated with this trait, with QTL/association found

   • ABCB1: ATP-binding cassette, sub-family B (MDR/TAP), member 1
     evidenced by: QTL:311819; QTL:311820;
   • ADAM12: ADAM metallopeptidase domain 12
     evidenced by: QTL:264113;
   • ARNT: Aryl hydrocarbon receptor nuclear translocator
     evidenced by: QTL:312648; QTL:312652; QTL:312654; QTL:312655; QTL:312657;
   • BMPR1B: Bone morphogenetic protein receptor, type IB
     evidenced by: QTL:264134;
   • BTBD3: BTB domain containing 3
     evidenced by: QTL:264119;
   • CAMKMT: Calmodulin-lysine N-methyltransferase
     evidenced by: QTL:121987; QTL:121990; QTL:121993; QTL:121995; QTL:121998; QTL:122001; QTL:122006; QTL:122009;
   • CAPN6: Calpain 6
     evidenced by: QTL:213858; QTL:213859;
   • CAST: Calpastatin
     evidenced by: QTL:160731;
   • CD8B: CD8b molecule
     evidenced by: QTL:255208; QTL:255209; QTL:255210; QTL:255211; QTL:255212; QTL:255213;
   • CEBPD: CCAAT/enhancer binding protein (C/EBP), delta
     evidenced by: QTL:122125;
   • CEP152: Centrosomal protein 152
     evidenced by: QTL:288176;
   • CROT: Carnitine O-octanoyltransferase
     evidenced by: QTL:264135;
   • DAAM1: Dishevelled associated activator of morphogenesis 1
     evidenced by: QTL:101282; QTL:101293;
   • DCC: DCC netrin 1 receptor
     evidenced by: QTL:285018;
   • DGAT1: Diacylglycerol O-acyltransferase 1
     evidenced by: QTL:160733; QTL:160735; QTL:160738;
   • DGAT2: Diacylglycerol O-acyltransferase 2
     evidenced by: QTL:160739;
   • DLG2: Discs large MAGUK scaffold protein 2
     evidenced by: QTL:277201;
   • DUSP5: Dual specificity phosphatase 5
     evidenced by: QTL:312606;
   • ESRP1: Epithelial splicing regulatory protein 1
     evidenced by: QTL:312603;
   • FGF5: Fibroblast growth factor 5
     evidenced by: QTL:238788; QTL:238789;
   • GH: Growth hormone
     evidenced by: QTL:57914; QTL:57918; QTL:57922; QTL:57926; QTL:57930;
   • GHR: Growth hormone receptor
     evidenced by: QTL:160732;
   • GHRHR: Growth hormone releasing hormone receptor
     evidenced by: QTL:160734; QTL:160737;
   • HSPB1: Heat shock protein family B (small) member 1
     evidenced by: QTL:160736;
   • ITGA11: Integrin subunit alpha 11
     evidenced by: QTL:213857;
   • JADE2: Jade family PHD finger 2
     evidenced by: QTL:101285;
   • KAT6A: Lysine acetyltransferase 6A
     evidenced by: QTL:257569;
   • KLF15: KLF transcription factor 15
     evidenced by: QTL:261898; QTL:261899; QTL:261900; QTL:261901; QTL:261902;
   • LEP: Leptin
     evidenced by: QTL:193121;
   • LEPR: Leptin receptor
     evidenced by: QTL:57509; QTL:57510; QTL:57511;
   • LOC101101875: Histone-lysine N-methyltransferase PRDM9
     evidenced by: QTL:264114; QTL:264120;
   • LOC101115632: Phospholipid-transporting ATPase IB
     evidenced by: QTL:218576;
   • LOC114108766: 60S ribosomal protein L17
     evidenced by: QTL:264131;
   • MAN1A1: Mannosidase, alpha, class 1A, member 1
     evidenced by: QTL:101288;
   • MED27: Mediator complex subunit 27
     evidenced by: QTL:285022;
   • MEF2B: Myocyte enhancer factor 2B
     evidenced by: QTL:107236; QTL:107238;
   • MSTN: Myostatin
     evidenced by: QTL:57451; QTL:57452; QTL:57453; QTL:57456; QTL:57457; QTL:57458; QTL:66097;
   • MTR: 5-methyltetrahydrofolate-homocysteine methyltransferase
     evidenced by: QTL:95226;
   • NCAPG: Non-SMC condensin I complex subunit G
     evidenced by: QTL:286352; QTL:286356; QTL:286360; QTL:286370; QTL:286374; QTL:286378; QTL:286388; QTL:286392; QTL:286396; QTL:286406; QTL:286410; QTL:286414; QTL:286418;
   • NPPC: Natriuretic peptide C
     evidenced by: QTL:288174;
   • PADI1: Peptidyl arginine deiminase 1
     evidenced by: QTL:264124;
   • PARD3B: Par-3 family cell polarity regulator beta
     evidenced by: QTL:285021;
   • PFKFB4: 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
     evidenced by: QTL:57807;
   • PHIP: Pleckstrin homology domain interacting protein
     evidenced by: QTL:312614;
   • PLA2G6: Phospholipase A2, group VI
     evidenced by: QTL:57806;
   • PLCB4: Phospholipase C beta 4
     evidenced by: QTL:285016;
   • PLXDC2: Plexin domain containing 2
     evidenced by: QTL:218577;
   • POMC: Proopiomelanocortin
     evidenced by: QTL:281273; QTL:281279; QTL:281285; QTL:281291;
   • PRKAA2: Protein kinase AMP-activated catalytic subunit alpha 2
     evidenced by: QTL:286799; QTL:286800; QTL:286801; QTL:286802; QTL:286804; QTL:286805;
   • PRSS12: Protease, serine 12
     evidenced by: QTL:101286;
   • PTPRT: Protein tyrosine phosphatase receptor type T
     evidenced by: QTL:312609;
   • SCAP: SREBF chaperone
     evidenced by: QTL:160740;
   • SCMH1: Scm polycomb group protein homolog 1
     evidenced by: QTL:213856;
   • SPAG8: Sperm associated antigen 8
     evidenced by: QTL:218888;
   • SSTR1: Somatostatin receptor 1
     evidenced by: QTL:256101; QTL:256104; QTL:256113;
   • SSTR5: Somatostatin receptor 5
     evidenced by: QTL:257724;
   • SYNE1: Spectrin repeat containing, nuclear envelope 1
     evidenced by: QTL:101289;
   • TEAD1: TEA domain transcription factor 1
     evidenced by: QTL:312607;
   • TMEM8B: Transmembrane protein 8B
     evidenced by: QTL:218887;
   • TMTC2: Transmembrane O-mannosyltransferase targeting cadherins 2
     evidenced by: QTL:285008;
   • TRHDE: Thyrotropin-releasing hormone degrading enzyme
     evidenced by: QTL:107232; QTL:107234;
   • ZNF641: Zinc finger protein 641
     evidenced by: QTL:312611;
   1963 correlations are found involving Body weight
    

2. Trait name:	Body weight change
   Ontology terms:	VT:0001259, CMO:0002045

   4 genes are associated with this trait, with QTL/association found

   • ACVRL1: Activin A receptor type II-like 1
     evidenced by: QTL:57495;
   • GPR84: G protein-coupled receptor 84
     evidenced by: QTL:57496;
   • MIEF1: Mitochondrial elongation factor 1
     evidenced by: QTL:57503;
   • TARBP2: TAR (HIV-1) RNA binding protein 2
     evidenced by: QTL:57497;